How Do U.S. Medical Oncologists Learn and Apply New Clinical Trials Information from Press Releases in Nonmedical Media? A Case Study Based on ECOG 4599

How Do U.S. Medical Oncologists Learn and Apply New Clinical Trials Information from Press Releases in Nonmedical Media? A Case Study Based on ECOG 4599 Daniel Dornbusch, Carmen Allegra, Joanne Willey, Michele Andrews, Richard Leff, James Epstein, James Jones, Lee Lokey, Mark R. Green Oncologist 2006; 11: 31-38 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in lung cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss new vehicles for the initial release of practice-relevant phase III clinical trial data. Describe the limited educational impact of such information transfer vehicles on the medical oncology community. Explain the potential risks to medical oncologists and their patients because of underinformed or non–evidence-based therapeutic recommendations involving new indications for commercially available agents. Discuss the development of new strategies for effective knowledge transfer of preliminary, practice-relevant, clinical trial data. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jan. 09, 2006 Most Recent Review: May 8, 2007* Most Recent Update: Jan. 09, 2006 Date Credit Expires: Jan. 09, 2008 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.